The DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
The Regulation of Bone Metabolism and Disorders by Wnt Signaling
Open accessAbstract
Wnt, a secreted glycoprotein, has an approximate molecular weight of 40 kDa, and it is a cytokine involved in various biological phenomena including ontogeny, morphogenesis, carcinogenesis, and maintenance of stem cells. The Wnt signaling pathway can be classified into two main pathways: canonical and non-canonical. Of these, the canonical Wnt signaling pathway promotes osteogenesis. Sclerostin produced by osteocytes is an inhibitor of this pathway, thereby inhibiting osteogenesis. Recently, osteoporosis treatment using an anti-sclerostin therapy has been introduced. In this review, the basics of Wnt signaling, its role in bone metabolism and its involvement in skeletal disorders have been covered. Furthermore, the clinical significance and future scopes of Wnt signaling in osteoporosis, osteoarthritis, rheumatoid arthritis and neoplasia are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Nusse, R., & Clevers, H. (2017) · Cell · doi:10.1016/j.cell.2017.05.016 · Cited by 4,342
Integrative Clinical Genomics of Advanced Prostate Cancer
Robinson, D., Van Allen, E. M., Wu, Y.-M., Schultz, N., Lonigro, R. J., Mosquera, J.-M., Montgomery, B., Taplin, M.-E., Pritchard, C. C., Attard, G., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.001 · Cited by 3,645
Genomic analyses identify molecular subtypes of pancreatic cancer
Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A.-M., Gingras, M.-C., Miller, D. K., Christ, A. N., Bruxner, T. J. C., Quinn, M. C., et al. (2016) · Nature · doi:10.1038/nature16965 · Cited by 3,621
LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development
Gong, Y., Slee, R. B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A. M., Wang, H., Cundy, T., Glorieux, F. H., Lev, D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00571-2 · Cited by 2,235
WNT signaling in bone homeostasis and disease: From human mutations to treatments
Baron, R., & Kneissel, M. (2013) · Nature Medicine · doi:10.1038/nm.3074 · Cited by 2,093
Smolen, J. S., Landewé, R., Bijlsma, J., Burmester, G., Chatzidionysiou, K., Dougados, M., Nam, J., Ramiro, S., Voshaar, M., van Vollenhoven, R., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210715 · Cited by 2,057
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992) · Nature · doi:10.1038/359162a0 · Cited by 1,907
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
Cosman, F., Crittenden, D. B., Adachi, J. D., Binkley, N., Czerwinski, E., Ferrari, S., Hofbauer, L. C., Lau, E., Lewiecki, E. M., Miyauchi, A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607948 · Cited by 1,805
Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction
Glinka, A., Wu, W., Delius, H., Monaghan, A. P., Blumenstock, C., & Niehrs, C. (1998) · Nature · doi:10.1038/34848 · Cited by 1,608
Canonical wnt signaling in differentiated osteoblasts controls osteoclast differentiation.
Glass, D. A., Bialek, P., Ahn, J. D., Starbuck, M., Patel, M. S., Clevers, H., Taketo, M. M., Long, F., McMahon, A. P., Lang, R. A., et al. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.02.017 · Cited by 1,558
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
Saag, K. G., Petersen, J., Brandi, M. L., Karaplis, A. C., Lorentzon, M., Thomas, T., Maddox, J., Fan, M., Meisner, P. D., & Grauer, A. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708322 · Cited by 1,544
Dickkopf-1 is a master regulator of joint remodeling
Diarra, D., Stolina, M., Polzer, K., Zwerina, J., Ominsky, M. S., Dwyer, D., Korb, A., Smolen, J., Hoffmann, M., Scheinecker, C., et al. (2007) · Nature Medicine · doi:10.1038/nm1538 · Cited by 1,298
Estrada, K., Styrkarsdottir, U., Evangelou, E., Hsu, Y.-H., Duncan, E. L., Ntzani, E. E., Oei, L., Albagha, O. M. E., Amin, N., Kemp, J. P., et al. (2012) · Nature Genetics · doi:10.1038/ng.2249 · Cited by 1,174
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
Balemans, W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.5.537 · Cited by 1,147
Delattre, O., Zucman, J., Melot, T., Garau, X. S., Zucker, J.-M., Lenoir, G. M., Ambros, P. F., Sheer, D., Turc-Carel, C., Triche, T. J., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408043310503 · Cited by 1,107
Kato, M., Patel, M. S., Levasseur, R., Lobov, I., Chang, B. H.-J., Glass, D. A., Hartmann, C., Li, L., Hwang, T.-H., Brayton, C. F., et al. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200201089 · Cited by 1,086 · cited 1×
“LRP5 KO mice (LRP5-KO) exhibited osteoblast deficiency and decreased bone mass [57].”
BackgroundThe Osteocyte: An Endocrine Cell … and More
Dallas, S. L., Prideaux, M., & Bonewald, L. F. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1026 · Cited by 1,042
Brunkow, M. E., Gardner, J. C., Van Ness, J., Paeper, B. W., Kovacevich, B. R., Proll, S., Skonier, J. E., Zhao, L., Sabo, P. J., Fu, Y.-H., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318811 · Cited by 1,011
Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors
Koo, B.-K., Spit, M., Jordens, I., Low, T. Y., Stange, D. E., van de Wetering, M., van Es, J. H., Mohammed, S., Heck, A. J. R., Maurice, M. M., et al. (2012) · Nature · doi:10.1038/nature11308 · Cited by 980
ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner
Hao, H.-X., Xie, Y., Zhang, Y., Charlat, O., Oster, E., Avello, M., Lei, H., Mickanin, C., Liu, D., Ruffner, H., et al. (2012) · Nature · doi:10.1038/nature11019 · Cited by 972
Li, X., Ominsky, M. S., Niu, Q.-T., Sun, N., Daugherty, B., D'Agostin, D., Kurahara, C., Gao, Y., Cao, J., Gong, J., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080216 · Cited by 936
Rijsewijk, F., Schuermann, M., Wagenaar, E., Parren, P., Weigel, D., & Nusse, R. (1987) · Cell · doi:10.1016/0092-8674(87)90038-9 · Cited by 931
Regulation of osteoblastogenesis and bone mass by Wnt10b
Bennett, C. N., Longo, K. A., Wright, W. S., Suva, L. J., Lane, T. F., Hankenson, K. D., & MacDougald, O. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408742102 · Cited by 881
Lrp5 Controls Bone Formation by Inhibiting Serotonin Synthesis in the Duodenum
Yadav, V. K., Ryu, J.-H., Suda, N., Tanaka, K. F., Gingrich, J. A., Schütz, G., Glorieux, F. H., Chiang, C. Y., Zajac, J. D., Insogna, K. L., et al. (2008) · Cell · doi:10.1016/j.cell.2008.09.059 · Cited by 834
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
Liu, J., Pan, S., Hsieh, M. H., Ng, N., Sun, F., Wang, T., Kasibhatla, S., Schuller, A. G., Li, A. G., Cheng, D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314239110 · Cited by 831
Regulation of Proliferation, Differentiation and Functions of Osteoblasts by Runx2
Komori, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071694 · Cited by 822
Li, X., Ominsky, M. S., Warmington, K. S., Morony, S., Gong, J., Cao, J., Gao, Y., Shalhoub, V., Tipton, B., Haldankar, R., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081206 · Cited by 784
Osteoimmunology: evolving concepts in bone–immune interactions in health and disease
Tsukasaki, M., & Takayanagi, H. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0178-8 · Cited by 771
Bänziger, C., Soldini, D., Schütt, C., Zipperlen, P., Hausmann, G., & Basler, K. (2006) · Cell · doi:10.1016/j.cell.2006.02.049 · Cited by 764
the Genetic Factors for Osteoporosis (GEFOS) Consortium (2009) · Nature Genetics · doi:10.1038/ng.446 · Cited by 706
Wnt/beta-catenin pathway: modulating anticancer immune response
Pai, S. G., Carneiro, B. A., Mota, J. M., Costa, R., Leite, C. A., Barroso-Sousa, R., Kaplan, J. B., Chae, Y. K., & Giles, F. J. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0471-6 · Cited by 703
Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease
Balemans, W., Patel, N., Ebeling, M., Van Hul, E., Wuyts, W., Lacza, C., Dioszegi, M., Dikkers, F. G., Hildering, P., Willems, P. J., et al. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.2.91 · Cited by 698
Lrp4 is a receptor for Agrin and forms a complex with MuSK
Kim, N., Stiegler, A. L., Cameron, T. O., Hallock, P. T., Gomez, A. M., Huang, J. H., Hubbard, S. R., Dustin, M. L., & Burden, S. J. (2008) · Cell · doi:10.1016/j.cell.2008.10.002 · Cited by 676
The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength
de Lau, W., Peng, W. C., Gros, P., & Clevers, H. (2014) · Genes & Development · doi:10.1101/gad.235473.113 · Cited by 656
Secreted and transmembrane wnt inhibitors and activators
Cruciat, C.-M., & Niehrs, C. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a015081 · Cited by 646
Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors
Kim, H., Wrann, C. D., Jedrychowski, M., Vidoni, S., Kitase, Y., Nagano, K., Zhou, C., Chou, J., Parkman, V.-J. A., Novick, S. J., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.025 · Cited by 638
Gurney, A., Axelrod, F., Bond, C. J., Cain, J., Chartier, C., Donigan, L., Fischer, M., Chaudhari, A., Ji, M., Kapoun, A. M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120068109 · Cited by 614 · cited 2×
“[13,212,218] Phase1 (NCT 02005315) pancreatic cancer”
BackgroundMode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15
Nusse, R., van Ooyen, A., Cox, D., Fung, Y. K. T., & Varmus, H. (1984) · Nature · doi:10.1038/307131a0 · Cited by 612
Secretion of Wnt Ligands Requires Evi, a Conserved Transmembrane Protein
Bartscherer, K., Pelte, N., Ingelfinger, D., & Boutros, M. (2006) · Cell · doi:10.1016/j.cell.2006.04.009 · Cited by 580
Van Wesenbeeck, L., Cleiren, E., Gram, J., Beals, R. K., Bénichou, O., Scopelliti, D., Key, L., Renton, T., Bartels, C., Gong, Y., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/368277 · Cited by 568
Maeda, K., Kobayashi, Y., Udagawa, N., Uehara, S., Ishihara, A., Mizoguchi, T., Kikuchi, Y., Takada, I., Kato, S., Kani, S., et al. (2012) · Nature Medicine · doi:10.1038/nm.2653 · Cited by 542
Self-citationOsteoimmunology: The conceptual framework unifying the immune and skeletal systems
Okamoto, K., Nakashima, T., Shinohara, M., Negishi-Koga, T., Komatsu, N., Terashima, A., Sawa, S., Nitta, T., & Takayanagi, H. (2017) · Physiological Reviews · doi:10.1152/physrev.00036.2016 · Cited by 534
Deletion of a Single Allele of the Dkk1 Gene Leads to an Increase in Bone Formation and Bone Mass
Morvan, F., Boulukos, K., Clément-Lacroix, P., Roman, S. R., Suc-Royer, I., Vayssière, B., Ammann, P., Martin, P., Pinho, S., Pognonec, P., et al. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060311 · Cited by 524
Langdahl, B. L., Libanati, C., Crittenden, D. B., Bolognese, M. A., Brown, J. P., Daizadeh, N. S., Dokoupilova, E., Engelke, K., Finkelstein, J. S., Genant, H. K., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31613-6 · Cited by 497
Zhu, M., Tang, D., Wu, Q., Hao, S., Chen, M., Xie, C., Rosier, R. N., O'Keefe, R. J., Zuscik, M., & Chen, D. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080901 · Cited by 476
Kemp, J. P., Morris, J. A., Medina-Gomez, C., Forgetta, V., Warrington, N. M., Youlten, S. E., Zheng, J., Gregson, C. L., Grundberg, E., Trajanoska, K., et al. (2017) · Nature Genetics · doi:10.1038/ng.3949 · Cited by 465
Lrp5 functions in bone to regulate bone mass
Cui, Y., Niziolek, P. J., MacDonald, B. T., Zylstra, C. R., Alenina, N., Robinson, D. R., Zhong, Z., Matthes, S., Jacobsen, C. M., Conlon, R. A., et al. (2011) · Nature Medicine · doi:10.1038/nm.2388 · Cited by 453
Cartilage-specific deletion of mTOR upregulates autophagy and protects mice from osteoarthritis
Zhang, Y., Vasheghani, F., Li, Y.-H., Blati, M., Simeone, K., Fahmi, H., Lussier, B., Roughley, P., Lagares, D., Pelletier, J.-P., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204599 · Cited by 412
Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes
O'Brien, C. A., Plotkin, L. I., Galli, C., Goellner, J. J., Gortazar, A. R., Allen, M. R., Robling, A. G., Bouxsein, M., Schipani, E., Turner, C. H., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002942 · Cited by 390
LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption
Luo, J., Yang, Z., Ma, Y., Yue, Z., Lin, H., Qu, G., Huang, J., Dai, W., Li, C., Zheng, C., et al. (2016) · Nature Medicine · doi:10.1038/nm.4076 · Cited by 370 · cited 1×
“LGR4 has been shown to function as a second receptor of RANKL and suppresses the differentiation and function of osteoclasts [73] (Table 2).”
BackgroundWNT1 Mutations in Early-Onset Osteoporosis and Osteogenesis Imperfecta
Laine, C. M., Joeng, K. S., Campeau, P. M., Kiviranta, R., Tarkkonen, K., Grover, M., Lu, J. T., Pekkinen, M., Wessman, M., Heino, T. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215458 · Cited by 365
Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines
Pukrop, T., Klemm, F., Hagemann, T., Gradl, D., Schulz, M., Siemes, S., Trümper, L., & Binder, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509703103 · Cited by 363
Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures
Movérare-Skrtic, S., Henning, P., Liu, X., Nagano, K., Saito, H., Börjesson, A. E., Sjögren, K., Windahl, S. H., Farman, H., Kindlund, B., et al. (2014) · Nature Medicine · doi:10.1038/nm.3654 · Cited by 361
Effect of the wingless (wg1) mutation on wing and haltere development in Drosophila melanogaster
Sharma, R. P., & Chopra, V. L. (1976) · Developmental Biology · doi:10.1016/0012-1606(76)90108-1 · Cited by 355
Wnt addiction of genetically defined cancers reversed by PORCN inhibition
Madan, B., Ke, Z., Harmston, N., Ho, S. Y., Frois, A. O., Alam, J., Jeyaraj, D. A., Pendharkar, V, Ghosh, K., Virshup, I. H., et al. (2016) · Oncogene · doi:10.1038/onc.2015.280 · Cited by 341
A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma
Tammela, T., Sanchez-Rivera, F. J., Cetinbas, N. M., Wu, K., Joshi, N. S., Helenius, K., Park, Y., Azimi, R., Kerper, N. R., Wesselhoeft, R. A., et al. (2017) · Nature · doi:10.1038/nature22334 · Cited by 336
Zisimopoulou, P., Evangelakou, P., Tzartos, J., Lazaridis, K., Zouvelou, V., Mantegazza, R., Antozzi, C., Andreetta, F., Evoli, A., Deymeer, F., et al. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.12.004 · Cited by 329
Lewiecki, E. M., Blicharski, T., Goemaere, S., Lippuner, K., Meisner, P. D., Miller, P. D., Miyauchi, A., Maddox, J., Chen, L., & Horlait, S. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02163 · Cited by 328
Mirza, F. S., Padhi, I. D., Raisz, L. G., & Lorenzo, J. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2283 · Cited by 311
Expression and function of wingless and frizzled homologs in rheumatoid arthritis
Sen, M., Lauterbach, K., El-Gabalawy, H., Firestein, G. S., Corr, M., & Carson, D. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050574297 · Cited by 311
Differential effects on lung and bone metastasis of breast cancer by Wnt signalling inhibitor DKK1
Zhuang, X., Zhang, H., Li, X., Li, X., Cong, M., Peng, F., Yu, J., Zhang, X., Yang, Q., & Hu, G. (2017) · Nature Cell Biology · doi:10.1038/ncb3613 · Cited by 309
Clinical subsequent fractures cluster in time after first fractures
van Geel, T. A. C. M., van Helden, S., Geusens, P. P., Winkens, B., & Dinant, G.-J. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.092775 · Cited by 308
Bone Overgrowth-associated Mutations in the LRP4 Gene Impair Sclerostin Facilitator Function
Leupin, O., Piters, E., Halleux, C., Hu, S., Kramer, I., Morvan, F., Bouwmeester, T., Schirle, M., Bueno-Lozano, M., Ramos Fuentes, F. J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.190330 · Cited by 301
Walker, E. C., McGregor, N. E., Poulton, I. J., Solano, M., Pompolo, S., Fernandes, T. J., Constable, M. J., Nicholson, G. C., Zhang, J.-G., Nicola, N. A., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40568 · Cited by 300
Wnt signaling and cellular metabolism in osteoblasts
Karner, C. M., & Long, F. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2425-5 · Cited by 295
Mutations in WNT1 Cause Different Forms of Bone Fragility
Keupp, K., Beleggia, F., Kayserili, H., Barnes, A. M., Steiner, M., Semler, O., Fischer, B., Yigit, G., Janda, C. Y., Becker, J., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.02.010 · Cited by 289
Deficiency of PORCN, a regulator of Wnt signaling, is associated with focal dermal hypoplasia
Grzeschik, K.-H., Bornholdt, D., Oeffner, F., König, A., del Carmen Boente, M., Enders, H., Fritz, B., Hertl, M., Grasshoff, U., Höfling, K., et al. (2007) · Nature Genetics · doi:10.1038/ng2052 · Cited by 285
Wnt10b Increases Postnatal Bone Formation by Enhancing Osteoblast Differentiation
Bennett, C. N., Ouyang, H., Ma, Y. L., Zeng, Q., Gerin, I., Sousa, K. M., Lane, T. F., Krishnan, V., Hankenson, K. D., & MacDougald, O. A. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070810 · Cited by 281
Osteocytes mediate the anabolic actions of canonical Wnt/β-catenin signaling in bone
Tu, X., Delgado-Calle, J., Condon, K. W., Maycas, M., Zhang, H., Carlesso, N., Taketo, M. M., Burr, D. B., Plotkin, L. I., & Bellido, T. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409857112 · Cited by 276
Kansara, M., Tsang, M., Kodjabachian, L., Sims, N. A., Trivett, M. K., Ehrich, M., Dobrovic, A., Slavin, J., Choong, P. F. M., Simmons, P. J., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37175 · Cited by 272
Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy
Wang, Z., Smith, K. S., Murphy, M., Piloto, O., Somervaille, T. C. P., & Cleary, M. L. (2008) · Nature · doi:10.1038/nature07284 · Cited by 265
Trajanoska, K., Morris, J. A., Oei, L., Zheng, H.-F., Evans, D. M., Kiel, D. P., Ohlsson, C., Richards, J. B., & Rivadeneira, F. (2018) · BMJ · doi:10.1136/bmj.k3225 · Cited by 265
Hoang, B. H., Kubo, T., Healey, J. H., Yang, R., Nathan, S. S., Kolb, E. A., Mazza, B., Meyers, P. A., & Gorlick, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1952 · Cited by 261
A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair
Florio, M., Gunasekaran, K., Stolina, M., Li, X., Liu, L., Tipton, B., Salimi-Moosavi, H., Asuncion, F. J., Li, C., Sun, B., et al. (2016) · Nature Communications · doi:10.1038/ncomms11505 · Cited by 257
Metastatic bone disease: Pathogenesis and therapeutic options
D'Oronzo, S., Coleman, R., Brown, J., & Silvestris, F. (2019) · Journal of Bone Oncology · doi:10.1016/j.jbo.2018.10.004 · Cited by 255
Targeting the Wnt pathway in human cancers: Therapeutic targeting with a focus on OMP-54F28
Le, P. N., McDermott, J. D., & Jimeno, A. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.08.005 · Cited by 253
Effects of Parathyroid Hormone Treatment on Circulating Sclerostin Levels in Postmenopausal Women
Drake, M. T., Srinivasan, B., Mödder, U. I., Peterson, J. M., McCready, L. K., Riggs, B. L., Dwyer, D., Stolina, M., Kostenuik, P., & Khosla, S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0720 · Cited by 251
Control of the SOST Bone Enhancer by PTH Using MEF2 Transcription Factors
Leupin, O., Kramer, I., Collette, N. M., Loots, G. G., Natt, F., Kneissel, M., & Keller, H. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070804 · Cited by 246
Osteocyte control of osteoclastogenesis
O'Brien, C. A., Nakashima, T., & Takayanagi, H. (2013) · Bone · doi:10.1016/j.bone.2012.08.121 · Cited by 235
Li, X., Warmington, K. S., Niu, Q.-T., Asuncion, F. J., Barrero, M., Grisanti, M., Dwyer, D., Stouch, B., Thway, T. M., Stolina, M., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.182 · Cited by 231
Wnt4 signaling prevents skeletal aging and inflammation by inhibiting nuclear factor-κB
Yu, B., Chang, J., Liu, Y., Li, J., Kevork, K., Al-Hezaimi, K., Graves, D. T., Park, N.-H., & Wang, C.-Y. (2014) · Nature Medicine · doi:10.1038/nm.3586 · Cited by 230
Chang, J., Sonoyama, W., Wang, Z., Jin, Q., Zhang, C., Krebsbach, P. H., Giannobile, W., Shi, S., & Wang, C.-Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702391200 · Cited by 226
Wnt signaling in cartilage development and diseases: lessons from animal studies
Usami, Y., Gunawardena, A. T., Iwamoto, M., & Enomoto-Iwamoto, M. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2015.142 · Cited by 224
Deshmukh, V., Hu, H., Barroga, C., Bossard, C., KC, S., Dellamary, L., Stewart, J., Chiu, K., Ibanez, M., Pedraza, M., et al. (2018) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2017.08.015 · Cited by 222
Bonnet, N., Standley, K. N., Bianchi, E. N., Stadelmann, V., Foti, M., Conway, S. J., & Ferrari, S. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.060335 · Cited by 214
LRP5 and Wnt Signaling: A Union Made for Bone
Johnson, M. L., Harnish, K., Nusse, R., & Van Hul, W. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040816 · Cited by 212
Katoh, M. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3689 · Cited by 211
Jimeno, A., Gordon, M., Chugh, R., Messersmith, W., Mendelson, D., Dupont, J., Stagg, R., Kapoun, A. M., Xu, L., Uttamsingh, S., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2157 · Cited by 209
Pyott, S. M., Tran, T. T., Leistritz, D. F., Pepin, M. G., Mendelsohn, N. J., Temme, R. T., Fernandez, B. A., Elsayed, S. M., Elsobky, E., Verma, I., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.02.009 · Cited by 208
Molecular genetics and targeted therapy of WNT-related human diseases (Review)
Katoh, M., & Katoh, M. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3071 · Cited by 207
Short-term and long-term effects of osteoporosis therapies
Reid, I. R. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.71 · Cited by 201
Miao, C.-G., Yang, Y.-Y., He, X., Li, X.-F., Huang, C., Huang, Y., Zhang, L., Lv, X.-W., Jin, Y., & Li, J. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.04.002 · Cited by 201
Wnt5a Induces Endothelial Inflammation via β-Catenin–Independent Signaling
Kim, J., Kim, J., Kim, D. W., Ha, Y., Ihm, M. H., Kim, H., Song, K., & Lee, I. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000181 · Cited by 201
Mutations in WNT1 are a cause of osteogenesis imperfecta
Fahiminiya, S., Majewski, J., Mort, J., Moffatt, P., Glorieux, F. H., & Rauch, F. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101567 · Cited by 198
Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis
Chan, B. Y., Fuller, E. S., Russell, A. K., Smith, S. M., Smith, M. M., Jackson, M. T., Cake, M. A., Read, R. A., Bateman, J. F., Sambrook, P. N., et al. (2011) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2011.04.014 · Cited by 197
To Wnt or not to Wnt: the bone and joint health dilemma
Lories, R. J., Corr, M., & Lane, N. E. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.25 · Cited by 193
Choi, M. Y., Widhopf, G. F., Ghia, E. M., Kidwell, R. L., Hasan, M. K., Yu, J., Rassenti, L. Z., Chen, L., Chen, Y., Pittman, E., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.05.018 · Cited by 192
A Molecular Function Map of Ewing's Sarcoma
Kauer, M., Ban, J., Kofler, R., Walker, B., Davis, S., Meltzer, P., & Kovar, H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005415 · Cited by 191
R-spondin 2 is required for normal laryngeal-tracheal, lung and limb morphogenesis
Bell, S. M., Schreiner, C. M., Wert, S. E., Mucenski, M. L., Scott, W. J., & Whitsett, J. A. (2008) · Development · doi:10.1242/dev.013359 · Cited by 191
RSPO2 inhibition of RNF43 and ZNRF3 governs limb development independently of LGR4/5/6
Szenker-Ravi, E., Altunoglu, U., Leushacke, M., Bosso-Lefèvre, C., Khatoo, M., Thi Tran, H., Naert, T., Noelanders, R., Hajamohideen, A., Beneteau, C., et al. (2018) · Nature · doi:10.1038/s41586-018-0118-y · Cited by 190
Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation
Yu, J., Chen, L., Cui, B., Widhopf, G. F., Shen, Z., Wu, R., Zhang, L., Zhang, S., Briggs, S. P., & Kipps, T. J. (2015) · Journal of Clinical Investigation · doi:10.1172/jci83535 · Cited by 188
Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin
Albers, J., Keller, J., Baranowsky, A., Beil, F. T., Catala-Lehnen, P., Schulze, J., Amling, M., & Schinke, T. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201207142 · Cited by 186
McDonald, M. M., Reagan, M. R., Youlten, S. E., Mohanty, S. T., Seckinger, A., Terry, R. L., Pettitt, J. A., Simic, M. K., Cheng, T. L., Morse, A., et al. (2017) · Blood · doi:10.1182/blood-2017-03-773341 · Cited by 185
Lietman, C., Wu, B., Lechner, S., Shinar, A., Sehgal, M., Rossomacha, E., Datta, P., Sharma, A., Gandhi, R., Kapoor, M., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.96308 · Cited by 185
Osteocyte-specific WNT1 regulates osteoblast function during bone homeostasis
Joeng, K. S., Lee, Y.-C., Lim, J., Chen, Y., Jiang, M.-M., Munivez, E., Ambrose, C., & Lee, B. H. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92617 · Cited by 180
Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling
Enomoto, M., Hayakawa, S., Itsukushima, S., Ren, D. Y., Matsuo, M., Tamada, K., Oneyama, C., Okada, M., Takumi, T., Nishita, M., et al. (2009) · Oncogene · doi:10.1038/onc.2009.175 · Cited by 179
Regulation of bone formation and remodeling by G-protein-coupled receptor 48
Luo, J., Zhou, W., Zhou, X., Li, D., Weng, J., Yi, Z., Cho, S. G., Li, C., Yi, T., Wu, X., et al. (2009) · Development · doi:10.1242/dev.033571 · Cited by 178
Wntless functions in mature osteoblasts to regulate bone mass
Zhong, Z., Zylstra-Diegel, C. R., Schumacher, C. A., Baker, J. J., Carpenter, A. C., Rao, S., Yao, W., Guan, M., Helms, J. A., Lane, N. E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120407109 · Cited by 178
Cell Death in Chondrocytes, Osteoblasts, and Osteocytes
Komori, T. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122045 · Cited by 176 · cited 1×
“OA is a degenerative disease associated with articular cartilage damage, osteophyte formation, and hardening of the subchondral bone [152,153].”
BackgroundSapir-Koren, R., & Livshits, G. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2808-0 · Cited by 176
Safely targeting cancer stem cells via selective catenin coactivator antagonism
Lenz, H., & Kahn, M. (2014) · Cancer Science · doi:10.1111/cas.12471 · Cited by 175
Barrott, J. J., Cash, G. M., Smith, A. P., Barrow, J. R., & Murtaugh, L. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006437108 · Cited by 174
Li, Y., Pawlik, B., Elcioglu, N., Aglan, M., Kayserili, H., Yigit, G., Percin, F., Goodman, F., Nürnberg, G., Cenani, A., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.03.004 · Cited by 171
Noncanonical Wnt5a enhances Wnt/β-catenin signaling during osteoblastogenesis
Okamoto, M., Udagawa, N., Uehara, S., Maeda, K., Yamashita, T., Nakamichi, Y., Kato, H., Saito, N., Minami, Y., Takahashi, N., et al. (2014) · Scientific Reports · doi:10.1038/srep04493 · Cited by 166
Self-citationSonomoto, K., Yamaoka, K., Oshita, K., Fukuyo, S., Zhang, X., Nakano, K., Okada, Y., & Tanaka, Y. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34555 · Cited by 163
SIKs control osteocyte responses to parathyroid hormone
Wein, M. N., Liang, Y., Goransson, O., Sundberg, T. B., Wang, J., Williams, E. A., O’Meara, M. J., Govea, N., Beqo, B., Nishimori, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms13176 · Cited by 163
Weivoda, M. M., Ruan, M., Hachfeld, C. M., Pederson, L., Howe, A., Davey, R. A., Zajac, J. D., Kobayashi, Y., Williams, B. O., Westendorf, J. J., et al. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2599 · Cited by 159
Self-citationHDAC5 Controls MEF2C-Driven Sclerostin Expression in Osteocytes
Wein, M. N., Spatz, J., Nishimori, S., Doench, J., Root, D., Babij, P., Nagano, K., Baron, R., Brooks, D., Bouxsein, M., et al. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2381 · Cited by 158
Bonnet, N., Conway, S. J., & Ferrari, S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203085109 · Cited by 158
WNT7B Promotes Bone Formation in part through mTORC1
Chen, J., Tu, X., Esen, E., Joeng, K. S., Lin, C., Arbeit, J. M., Rüegg, M. A., Hall, M. N., Ma, L., & Long, F. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004145 · Cited by 153
Glorieux, F. H., Devogelaer, J., Durigova, M., Goemaere, S., Hemsley, S., Jakob, F. J., JUNKER, U., Ruckle, J., Seefried, L., & Winkle, P. J. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3143 · Cited by 153
Cortical-Bone Fragility — Insights from sFRP4 Deficiency in Pyle’s Disease
Simsek Kiper, P. O., Saito, H., Gori, F., Unger, S., Hesse, E., Yamana, K., Kiviranta, R., Solban, N., Liu, J., Brommage, R., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1509342 · Cited by 151 · cited 2×
“1) Loss-of-function (AR) Pyle disease metaphyseal dysplasia 265900 wide trabecular metaphyses, thin cortical bone, bone fragility [33]”
BackgroundMultistage genome-wide association meta-analyses identified two new loci for bone mineral density
Zhang, L., Choi, H. J., Estrada, K., Leo, P. J., Li, J., Pei, Y., Zhang, Y., Lin, Y., Shen, H., Liu, Y.-Z., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt575 · Cited by 151
Sclerostin expression and functions beyond the osteocyte
Weivoda, M. M., Youssef, S. J., & Oursler, M. J. (2016) · Bone · doi:10.1016/j.bone.2016.11.024 · Cited by 148
Expression Profiles and Functional Analyses of Wnt-Related Genes in Human Joint Disorders
Nakamura, Y., Nawata, M., & Wakitani, S. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62957-4 · Cited by 141
Sclerostin inhibition promotes TNF-dependent inflammatory joint destruction
Wehmeyer, C., Frank, S., Beckmann, D., Böttcher, M., Cromme, C., König, U., Fennen, M., Held, A., Paruzel, P., Hartmann, C., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aac4351 · Cited by 141
Takeuchi, T., Tanaka, Y., Soen, S., Yamanaka, H., Yoneda, T., Tanaka, S., Nitta, T., Okubo, N., Genant, H. K., & van der Heijde, D. M. F. M. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214827 · Cited by 141
Effects of sclerostin antibodies in animal models of osteoporosis
Ominsky, M. S., Boyce, R. W., Li, X., & Ke, H. Z. (2016) · Bone · doi:10.1016/j.bone.2016.10.019 · Cited by 140
Lintern, K., Guidato, S., Rowe, A., Saldanha, J. W., & Itasaki, N. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.025478 · Cited by 139
DNA methylation contributes to the regulation of sclerostin expression in human osteocytes
Delgado‐Calle, J., Sañudo, C., Bolado‐Carrancio, A., Fernández, A. F., Arozamena, J., Pascual-Carra, M. A., Rodríguez-Rey, J. C., Fraga, M. F., Bonewald, L. F., & Riancho, J. A. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1491 · Cited by 139
Estrogen receptor α in osteocytes regulates trabecular bone formation in female mice
Kondoh, S., Inoue, K., Igarashi, K., Sugizaki, H., Shirode-Fukuda, Y., Inoue, E., Yu, T., Takeuchi, J., Kanno, J., Bonewald, L. F., et al. (2013) · Bone · doi:10.1016/j.bone.2013.12.005 · Cited by 138
Delgado‐Calle, J., Anderson, J. L., Cregor, M. D., Condon, K. W., Kuhstoss, S., Plotkin, L. I., Bellido, T., & Roodman, G. D. (2017) · Leukemia · doi:10.1038/leu.2017.152 · Cited by 134
Chang, M.-K., Krämer, I., Huber, T., Kinzel, B., Guth, S., Leupin, O., & Kneissel, M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413828111 · Cited by 133
Patton, M. A., & Afzal, A. R. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.5.305 · Cited by 133
Control of bone formation by the serpentine receptor Frizzled-9
Albers, J., Schulze, J., Beil, F. T., Gebauer, M., Baranowsky, A., Keller, J., Marshall, R. P., Wintges, K., Friedrich, F. W., Priemel, M., et al. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201008012 · Cited by 131
Wnt11 Promotes Osteoblast Maturation and Mineralization through R-spondin 2
Friedman, M. S., Oyserman, S. M., & Hankenson, K. D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808337200 · Cited by 130
Osteoblast-Targeted Expression of Sfrp4 in Mice Results in Low Bone Mass
Nakanishi, R., Akiyama, H., Kimura, H. J., Otsuki, B., Shimizu, M., Tsuboyama, T., & Nakamura, T. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.071007 · Cited by 129
Roles of Wnt signals in bone resorption during physiological and pathological states
Maeda, K., Takahashi, N., & Kobayashi, Y. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0974-0 · Cited by 127
Self-citationTargeting sphingosine-1-phosphate lyase as an anabolic therapy for bone loss
Weske, S., Vaidya, M., Reese, A., Lipinski, K. V. W., Keul, P., Bayer, J. K., Fischer, J. W., Flögel, U., Nelsen, J., Epple, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0005-y · Cited by 127
Osteocytic oxygen sensing controls bone mass through epigenetic regulation of sclerostin
Stegen, S., Stockmans, I., Moermans, K., Thienpont, B., Maxwell, P. H., Carmeliet, P., & Carmeliet, G. (2018) · Nature Communications · doi:10.1038/s41467-018-04679-7 · Cited by 126 · cited 1×
“On the other hand, hypoxia increases Sirtuin 1-dependent deacetylation of the Sost promoter, resulting in decreased sclerostin expression and enhanced Wnt/β-catenin signaling in osteocytes [89].”
BackgroundR-spondin-2 is a Wnt agonist that regulates osteoblast activity and bone mass
Knight, M. N., Karuppaiah, K., Lowe, M., Mohanty, S., Zondervan, R. L., Bell, S. M., Ahn, J., & Hankenson, K. D. (2018) · Bone Research · doi:10.1038/s41413-018-0026-7 · Cited by 126
Gao, Y., Huang, E., Zhang, H., Wang, J., Wu, N., Chen, X., Wang, N., Wen, S., Nan, G., Deng, F., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082436 · Cited by 124
Rauner, M., Stein, N., Winzer, M., Goettsch, C., Zwerina, J., Schett, G. A., Distler, J. H. W., Albers, J., Schulze, J., Schinke, T., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1488 · Cited by 124
Bouaziz, W., Funck‐Brentano, T., Lin, H., Marty, C., Ea, H., Haÿ, E., & Cohen-Solal, M. E. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0540-6 · Cited by 122
Roforth, M. M., Fujita, K., McGregor, U. I., Kirmani, S., McCready, L. K., Peterson, J. M., Drake, M. T., Monroe, D. G., & Khosla, S. (2013) · Bone · doi:10.1016/j.bone.2013.10.019 · Cited by 121
Lrp5 and Lrp6 Exert Overlapping Functions in Osteoblasts during Postnatal Bone Acquisition
Riddle, R. C., Diegel, C. R., Leslie, J. M., van Koevering, K., Monier‐Faugere, M., Clemens, T. L., & Williams, B. O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063323 · Cited by 120
The osteocyte: key player in regulating bone turnover
Goldring, S. R. (2015) · RMD Open · doi:10.1136/rmdopen-2015-000049 · Cited by 119
Multi-lineage differentiation of mesenchymal stem cells – To Wnt, or not Wnt
Visweswaran, M., Pohl, S., Arfuso, F., Newsholme, P., Dilley, R. J., Pervaiz, S., & Dharmarajan, A. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.09.008 · Cited by 111
Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption
Xiong, L., Jung, J.-U., Wu, H., Xia, W.-F., Pan, J., Shen, C., Mei, L., & Xiong, W. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419714112 · Cited by 108
Insight into the Role of Wnt5a-Induced Signaling in Normal and Cancer Cells
Endo, M., Nishita, M., Fujii, M., & Minami, Y. (2014) · International review of cytology · doi:10.1016/bs.ircmb.2014.10.003 · Cited by 108
Bone loss from Wnt inhibition mitigated by concurrent alendronate therapy
Madan, B., McDonald, M. J., Foxa, G. E., Diegel, C. R., Williams, B. O., & Virshup, D. M. (2018) · Bone Research · doi:10.1038/s41413-018-0017-8 · Cited by 107
Stolina, M., Dwyer, D., Niu, Q., Villasenor, K. S., Kurimoto, P., Grisanti, M. S., Han, C.-Y. E., Liu, M., Li, X., Ominsky, M. S., et al. (2014) · Bone · doi:10.1016/j.bone.2014.07.031 · Cited by 105
Eda, H., Santo, L., Wein, M. N., Hu, D. Z., Cirstea, D. D., Nemani, N., Tai, Y., Raines, S. E., Kuhstoss, S. A., Munshi, N. C., et al. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2789 · Cited by 103
Sclerostin deficiency in humans
van Lierop, A. H., Appelman‐Dijkstra, N. M., & Papapoulos, S. E. (2016) · Bone · doi:10.1016/j.bone.2016.10.010 · Cited by 103
Sclerostin neutralization unleashes the osteoanabolic effects of Dkk1 inhibition
Witcher, P. C., Miner, S. E., Horan, D. J., Bullock, W. A., Lim, K., Kang, K. S., Adaniya, A. L., Ross, R. D., Loots, G. G., & Robling, A. G. (2018) · JCI Insight · doi:10.1172/jci.insight.98673 · Cited by 93
Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis
Chen, X., Baum, W., Dwyer, D., Stock, M., Schwabe, K., Ke, H.-Z., Stolina, M., Schett, G. A., & Bözec, A. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203345 · Cited by 90
Ewing’s sarcoma precursors are highly enriched in embryonic osteochondrogenic progenitors
Tanaka, M., Yamazaki, Y., Kanno, Y., Igarashi, K., Aisaki, K., Kanno, J., & Nakamura, T. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72399 · Cited by 89
Danieau, G., Morice, S., Rédiní, F., Verrecchia, F., & Royer, B. B.-L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153751 · Cited by 89
Weivoda, M. M., Ruan, M. M., Pederson, L. G., Hachfeld, C. M., Davey, R. A., Zajac, J. D., Westendorf, J. J., Khosla, S., & Oursler, M. J. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2586 · Cited by 86
Wnt1 is an Lrp5-independent bone-anabolic Wnt ligand
Luther, J., Yorgan, T. A., Rolvien, T., Ulsamer, L. P. L., Koehne, T., Liao, N., Keller, D. B., Vollersen, N., Teufel, S., Neven, M., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aau7137 · Cited by 85
Protein kinase N3 promotes bone resorption by osteoclasts in response to Wnt5a-Ror2 signaling
Uehara, S., Udagawa, N., Mukai, H., Ishihara, A., Maeda, K., Yamashita, T., Murakami, K., Nishita, M., Nakamura, T., Kato, S., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aan0023 · Cited by 83
Self-citationEfficacy of anti-sclerostin monoclonal antibody BPS804 in adult patients with hypophosphatasia
Seefried, L., Baumann, J., Hemsley, S., Hofmann, C., Kunstmann, E., Kiese, B., Huang, Y., Chivers, S., Valentin, M., Borah, B., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci83731 · Cited by 80
Sato, A., Kayama, H., Shojima, K., Matsumoto, S., Koyama, H., Minami, Y., Nojima, S., Morii, E., Honda, H., Takeda, K., et al. (2015) · Scientific Reports · doi:10.1038/srep10536 · Cited by 79
Bone Formation Is Coupled to Resorption Via Suppression of Sclerostin Expression by Osteoclasts
Koide, M., Kobayashi, Y., Yamashita, T., Uehara, S., Nakamura, M., Hiraoka, B. Y., Ozaki, Y., Iimura, T., Yasuda, H., Takahashi, N., et al. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3175 · Cited by 78
Self-citationHaraguchi, R., Kitazawa, R., Mori, K., Tachibana, R., Kiyonari, H., Imai, Y., Abe, T., & Kitazawa, S. (2016) · Scientific Reports · doi:10.1038/srep25198 · Cited by 77
Clinical immunity in bone and joints
Tanaka, Y. (2018) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-018-0965-5 · Cited by 77
Clinical advantages and disadvantages of anabolic bone therapies targeting the WNT pathway
Appelman‐Dijkstra, N. M., & Papapoulos, S. E. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0087-0 · Cited by 76
Styrkársdóttir, U., Þorleifsson, G., Gudjonsson, S. A., Sigurðsson, Á., Lee, S. H., Nguyen, T. V., Kwok, T. C. Y., Lee, J. S. W., Ho, S. C., Woo, J., et al. (2016) · Nature Communications · doi:10.1038/ncomms10129 · Cited by 75
Chung, Y., Lee, S. H., Lee, S.-Y., Kim, S.-Y., Kim, H.-H., Mirza, F., Lee, S.-K., Lorenzo, J. A., Kim, G. S., & Koh, J. (2011) · Osteoporosis International · doi:10.1007/s00198-011-1675-1 · Cited by 68
Sølling, A. S., Harsløf, T., & Langdahl, B. L. (2018) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x18775936 · Cited by 67
LRP4 in neuromuscular junction and bone development and diseases
Shen, C., Xiong, W., & Mei, L. (2015) · Bone · doi:10.1016/j.bone.2015.05.012 · Cited by 65
Fukuyo, S., Yamaoka, K., Sonomoto, K., Oshita, K., Okada, Y., Saito, K., Yoshida, Y., Kanazawa, T., Minami, Y., & Tanaka, Y. (2014) · Rheumatology · doi:10.1093/rheumatology/ket496 · Cited by 63
Giraudet, A., Cassier, P. A., Iwao-Fukukawa, C., Garin, G., Badel, J., Kryza, D., Chabaud, S., Gilles-Afchain, L., Clapisson, G., Desuzinges, C., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4544-x · Cited by 63
Sclerostin Antibody Therapy for the Treatment of Osteoporosis: Clinical Prospects and Challenges
MacNabb, C., Patton, D., & Hayes, J. S. (2016) · Journal of Osteoporosis · doi:10.1155/2016/6217286 · Cited by 62
Santiago, F., Oguma, J., Brown, A. M. C., & Laurence, J. C. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.11.089 · Cited by 61
Liu, W., Shaver, T. M., Balasa, A., Ljungberg, M. C., Wang, X., Wen, S., Nguyen, H., & den Veyver, I. B. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032331 · Cited by 60
Multiple Myeloma and Bone: The Fatal InteractionPreprint
Marino, S., & Roodman, G. D. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031286 · Cited by 59
LRP receptor family member associated bone disease
Lara-Castillo, N., & Johnson, M. L. (2015) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-015-9315-2 · Cited by 58
Lin, C. H., Guo, Y., Ghaffar, S., McQueen, P., Pourmorady, J. S., Christ, A. B., Rooney, K., Ji, T., Eskander, R. H., Zi, X., et al. (2013) · Sarcoma · doi:10.1155/2013/147541 · Cited by 57
Marenzana, M., Vugler, A., Moore, A., & Robinson, M. K. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4305 · Cited by 54
Colditz, J., Thiele, S., Baschant, U., Niehrs, C., Bonewald, L. F., Hofbauer, L. C., & Rauner, M. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3463 · Cited by 54
Aldinger, K. A., Mendelsohn, N. J., Chung, B. H., et al. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103476 · Cited by 52
Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer
Manegold, P., Lai, K., Wu, Y., Teo, J.-L., Lenz, H.-J., Genyk, Y., Pandol, S., Wu, K., Lin, D., Chen, Y., et al. (2018) · Cancers · doi:10.3390/cancers10040095 · Cited by 51 · cited 2×
“b-catenin b-catenin/CBP Inhibitor PRI-724 Phase1 (NCT 01764477) metastatic pancreatic cancer [13,212,219, 220] Phase1/2 (NCT 01606579) advanced myeloid malignancies”
BackgroundSerum Dickkopf 1 Levels in Sclerostin Deficiency
van Lierop, A. H., Moester, M. J. C., Hamdy, N. A. T., & Papapoulos, S. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3278 · Cited by 51
Non-canonical Wnt signals regulate cytoskeletal remodeling in osteoclasts
Uehara, S., Udagawa, N., & Kobayashi, Y. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2881-1 · Cited by 51
Self-citationSclerostin and Bone Aging: A Mini-Review
Haÿ, E., Bouaziz, W., Funck‐Brentano, T., & Cohen-Solal, M. E. (2016) · Gerontology · doi:10.1159/000446278 · Cited by 50
Secreted Frizzled-Related Protein 2 (sFRP2) promotes osteosarcoma invasion and metastatic potential
Techavichit, P., Gao, Y., Kurenbekova, L., Shuck, R. L., Donehower, L. A., & Yustein, J. T. (2016) · BMC Cancer · doi:10.1186/s12885-016-2909-6 · Cited by 50
Porcupine inhibitors impair trabecular and cortical bone mass and strength in mice
Funck‐Brentano, T., Nilsson, K. H., Brommage, R., Henning, P., Lerner, U. H., Koskela, A., Tuukkanen, J., Cohen-Solal, M. E., Movérare‐Skrtic, S., & Ohlsson, C. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0153 · Cited by 50
Regulatory mechanisms of sclerostin expression during bone remodeling
Koide, M., & Kobayashi, Y. (2018) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-018-0971-7 · Cited by 50
Self-citationClass I and IIa Histone Deacetylases Have Opposite Effects on Sclerostin Gene Regulation
Baertschi, S., Baur, N., Lueders-Lefevre, V., Voshol, J., & Keller, H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.564997 · Cited by 48
Local Control of Soft Tissue and Bone Sarcomas
Crompton, J. G., Ogura, K., Bernthal, N. M., Kawai, A., & Eilber, F. C. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.2717 · Cited by 48
van Bezooijen, R. L., DeRuiter, M. C., Vilain, N., Monteiro, R. M., Visser, A., van der Wee-Pals, L. J. A., van Munsteren, C. J., Hogendoorn, P. C. W., Aguet, M., Mummery, C. L., et al. (2006) · Developmental Dynamics · doi:10.1002/dvdy.21054 · Cited by 46
Shi, G.-X., Zheng, X., Zhu, C., Li, B., Wang, Y., Jiang, S., & Jiang, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030564 · Cited by 46
Recent advances in the management of osteoporosis
Fukumoto, S., & Matsumoto, T. (2017) · F1000Research · doi:10.12688/f1000research.10682.1 · Cited by 46
Adult T-cell leukemia cells overexpress Wnt5a and promote osteoclast differentiation
Bellon, M., Ko, N. L., Lee, M.-J., Yao, Y., Waldmann, T. A., Trepel, J. B., & Nicot, C. (2013) · Blood · doi:10.1182/blood-2012-07-439109 · Cited by 45
Wang, X., Liang, Y., Zhang, J., Li, H., & Wang, D. (2016) · Nephrology · doi:10.1111/nep.12813 · Cited by 45
Wnt Signaling in Ewing Sarcoma, Osteosarcoma, and Malignant Peripheral Nerve Sheath Tumors
Pridgeon, M. G., Grohar, P. J., Steensma, M. R., & Williams, B. O. (2017) · Current Osteoporosis Reports · doi:10.1007/s11914-017-0377-9 · Cited by 44
Elimination of Osteosarcoma by Necroptosis with Graphene Oxide-Associated Anti-HER2 Antibodies
Xiao, H., Jensen, P. E., & Chen, X. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184360 · Cited by 39
Świerkot, J., Gruszecka, K., Matuszewska, A., & Wiland, P. (2015) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-015-0338-x · Cited by 38
Concise Review: Defining and Targeting Myeloma Stem Cell‐Like Cells
Abe, M., Harada, T., & Matsumoto, T. (2014) · Stem Cells · doi:10.1002/stem.1643 · Cited by 37
Cited by
Current Status of the Diagnosis and Management of Osteoporosis
Aibar-Almazán, A., Voltes-Martínez, A., Castellote-Caballero, Y., Afanador-Restrepo, D. F., Carcelén-Fraile, M. D. C., & López-Ruiz, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169465 · Cited by 412
Wnt/β-catenin-driven EMT regulation in human cancers
Xue, W., Yang, L., Chen, C., Ashrafizadeh, M., Tian, Y., & Sun, R. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05099-7 · Cited by 321
Vlashi, R., Zhang, X., Wu, M., & Chen, G. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.07.011 · Cited by 165
The Development of Molecular Biology of Osteoporosis
Gao, Y., Patil, S., & Jia, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158182 · Cited by 116
Osteoclast-targeted delivery of anti-miRNA oligonucleotides by red blood cell extracellular vesicles
Xu, L., Xu, X., Liang, Y., Wen, C., Ouyang, K., Huang, J., Xiao, Y., Deng, X., Xia, J., & Duan, L. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.04.043 · Cited by 65
Metadata
- Authors
- Maeda, K., Kobayashi, Y., Koide, M., Uehara, S., Okamoto, M., Ishihara, A., Kayama, T., Saito, M., & Marumo, K.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-11-06
- Volume
- 20
- Issue
- 22
- Pages
- 5525
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2988684012
- Cited by
- 353
- References
- 223
- FWCI
- 10.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.